Compare Main Street Capital Corporation (MAIN) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Main Street Capital Corporation vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Main Street Capital Corporation trades at $53.67 (market cap $5.09B), while Nuvation Bio Inc. Class A Common Stock trades at $5.07 (market cap $1.74B). The key difference: Main Street Capital Corporation is far larger — about 2.9× Nuvation Bio Inc. Class A Common Stock's market cap, and Main Street Capital Corporation pays a 5.84% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Main Street Capital Corporation for 89 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| MAIN | NUVB | |
|---|---|---|
Market Cap | $5.09B | $1.74B |
Volume | 524,060 | 9,289,619 |
Sector | Financials | Health |
52-Week High | $64.60 | $9.54 |
52-Week Low | $49.63 | $3.41 |
Typical Hold Time | 89 Days | 1 Days |
Enterprise Value | $7.54B | $1.33B |
Dividend Yield | 5.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MAIN trades at $54.15, down slightly over the past day. The stock shows mixed technical signals with a bearish overall trend but oversold short-term RSI. Fundamentally, the company maintains strong profitability with an 80.77% net margin and a P/E of 10.94, though revenue is expected to decline in 2026. Recent earnings have been mixed with a beat in Q2 2026 but a miss in Q1 2026.
The outlook is cautious. Analyst consensus is a Hold with a $58.33 price target, implying modest upside. Risks include softening earnings and negative operating cash flow. The dividend remains well-covered, supporting income investors, but growth prospects appear limited near-term amid a bearish technical setup.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
